Chief Surgical Officer and Board-Certified Gynecologic Oncologist, Dr. Mark Shahin discusses what’s new from recent annual meetings, changes in funding and the future of cancer research, the impact of exercise, and the use of hormonal therapy in ovarian cancer treatment.
